Skip to main content
Clinical Trials/NCT01820182
NCT01820182CompletedNot Applicable

Prospective Comparison of the Diagnostic Yield of Small Bowel Pillcam SB2 and Capsocam Capsule in Patients With Obscure Digestive Bleedings

Hôpital Edouard Herriot0 sites73 target enrollmentStarted: January 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
73
Primary Endpoint
number of discordant films between the two capsules with two different readers

Study Overview

Brief Summary

Comparative, randomized study patients are scheduled to have two capsule endoscopies within 2 to 14 days from each other using two different endoscopies the Pillcam SB2 (Given Imaging, Israel) and the Capsocam (Capso Vision Saratoga United States) The order in which the devices are administered is randomly allocated.

Detailed Description

Objectives

Main objective

To compare the diagnostic yield of both capsules in the same patients with a satisfying concordance coefficient k>0,6

Secondary objectives

To compare the sensitivity and specificity of both capsule readings To copmpare the sensitivity and specificity for specific lesions classified in terms of relevance P0 P1 P2 To check the tecnical fiability (incidence of technical issues To check the feasibility To evaluate the rate of complete small bowel examination, the small bowel transit time the capsule reading time

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •over 18 years old
  • •obscure digestive bleeding justifying capsule endoscopy
  • •complete endoscopic work up including colonoscopy with ileoscopy and gastroscopy with aneathesia or sedation
  • •absence of concomittent ongoing study
  • •absence of occlusive symptoms of suspected Crohn's disease nor of previous small bowel radiotherapy
  • •filled inform consent
  • •no implanted pace maker
  • •patient being affiliated to the CPAM

Exclusion Criteria

  • •under 18 years old
  • •oral iron within 8 days before capsule endoscopy
  • •gastroparesis
  • •pacemaker
  • •swallowing troubles
  • •presence of oclusive symptoms suspected Crohn's disease nor of previous small bowel radiotherapy
  • •pregnancy or risk of pregnancy without efficient oral contraception
  • •absence of written informed consent

Arms & Interventions

capsocam capsula

Experimental

capsocam capsula readings

Intervention: capsule endoscopies (Device)

Outcomes

Primary Outcomes

number of discordant films between the two capsules with two different readers

Time Frame: 14 days

Reading of the two capsules film is randomized order by two different readers in each center

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jean Christophe Saurin

Proffessor

Hôpital Edouard Herriot

Similar Trials